DelSiTech will be attending CPHI Milan 2026, taking place on 6–8 October in Milan, Italy. As one of the world’s largest pharmaceutical industry events, CPHI brings together companies from across the pharmaceutical value chain, spanning drug development, manufacturing, drug delivery, packaging, and commercial supply.
DelSiTech’s proprietary Silica Matrix® platform enables long-acting delivery of a wide range of molecules, including small molecules, peptides, proteins, biologics, and vaccines. The matrix can be formulated to provide predetermined release profiles ranging from days to several months while utilizing a fully biodegradable silica-based material.
As demand for long-acting medicines continues to grow, we are expanding the applications based on Silica Matrix® across multiple therapeutic areas, including metabolic diseases, pain management, ophthalmology, and vaccine delivery. Our goal is to innovate new solutions and to help partners create differentiated products through advanced drug delivery.
We look forward to meeting both existing and prospective partners in Milan. DelSiTech’s BD Manager, Milla Runsala, will be attending throughout the conference and looks forward to discussing the latest developments in long-acting drug delivery and potential applications of Silica Matrix® for your needs.
Connect with us here or reach out directly at bd@delsitech.com to schedule a meeting.